Posted on December 7, 2007. Filed under: Anti-Viral |
Treatment Studies in Adult Patients
A total of 1171 patients who participated in adult phase III controlled clinical trials for the treatment of influenza were treated with TAMIFLU. The most frequently reported adverse events in these studies were nausea and vomiting. These events were generally of mild to moderate degree and usually [...]
Read Full Post |
Make a Comment ( None so far )
